After the successful introduction of CONSIGMA™ at the Interpack show in April 2008, the success story continues with yet another sale of this innovative continuous high-shear granulation and drying unit.
Based on feasibility trials of the CONSIGMA™ in the Process Development Center of GEA Pharma Systems nv - Collette™, another Mexican generic company has decided to buy a large capacity unit.
After evaluation of the quality of the produced granules and a comparison of investment and running costs between CONSIGMA™ and a traditional line, this company quickly realized the advantages of the continuous line and issued a purchase order.
Also an Eastern European generic player has decided to invest in the CONSIGMA™ for much the same reasons. They also witnessed successful trials in our laboratory in Wommelgem and after making the comparison of investment and running cost, they came to the same conclusions. In their decision, also space requirement played an important role, which is about ¼ for CONSIGMA™ compared to a traditional granulation suite.
For more information about CONSIGMA™, please visit www.consigma.be or contact GEA Pharma Systems nv – Collette™.